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Abstract
Background: Malaria presents a diagnostic challenge in most tropical countries. Microscopy remains the gold 
standard for diagnosing malaria infections in clinical practice and research. However, microscopy is labour intensive, 
requires significant skills and time, which causes therapeutic delays. The objective of obtaining result quickly from the 
examination of blood samples from patients with suspected malaria is now made possible with the introduction of 
rapid malaria diagnostic tests (RDTs). Several RDTs are available, which are fast, reliable and simple to use and can 
detect Plasmodium falciparum and non-falciparum infections or both. A study was conducted in tribal areas of central 
India to measure the overall performance of several RDTs for diagnosis of P. falciparum and non-falciparum infections in 
comparison with traditional and molecular techniques. Such data will be used to guide procurement decisions of 
policy makers and programme managers.
Methods: Five commercially available RDTs were tested simultaneously in field in parallel with peripheral blood smears 
in outbreak-affected areas. The evaluation is designed to provide comparative data on the performance of each RDT. In 
addition, molecular method i.e. polymerase chain reaction (PCR) was also carried out to compare all three methods.
Results: A total of 372 patients with a clinical suspicion of malaria from Bajag Primary Health Centre (PHC) of district 
Dindori and Satanwada PHC of district Shivpuri attending the field clinics of Regional Medical Research Centre were 
included in the study. The analysis revealed that the First Response Malaria Antigen pLDH/HRP2 combo test was 94.7% 
sensitive (95% CI 89.5-97.7) and 69.9% specific (95% CI 63.6-75.6) for P. falciparum. However, for non-falciparum 
infections (Plasmodium vivax) the test was 84.2% sensitive (95% CI 72.1-92.5) and 96.5% specific (95% CI 93.8-98.2). The 
Parascreen represented a good alternative. All other RDTs were relatively less sensitive for both P. falciparum and non-
falciparum infections.
Conclusions: The results in this study show comparative performance between microscopy, various RDTs and PCR. 
Despite some inherent limitation in the five RDTs tested, First Response clearly has an advantage over other RDTs. The 
results suggest that RDTs could play and will play an important role in malaria diagnosis.
Background
Malaria is a disease of global importance that results in
300 - 660 million cases annually and an estimated 2.2 bil-
lion people are at risk of infection [1]. Of the 2.5 million
reported cases in the South East Asia, India alone con-
tributes about 70% of the total malaria cases [2]. Cur-
rently, 80.5% of the 109 billion population of India lives in
malaria risk areas [3]. Malaria presents a diagnostic chal-
lenge in most resource poor areas where malaria is
endemic. In such areas malaria diagnosis is often made
only on the basis of clinical symptoms although this is
alarmingly inaccurate [4]. The role of the laboratory diag-
nosis of malaria is primarily to support clinical care [5].
The traditional method for the detection of the malaria
parasite is the examination of thick and thin blood smears
by microscopy. The shortcomings of microscopy for
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Page 2 of 13malaria diagnosis are well known [6,7]. These diagnostic
limitations affect medical care provided, as malaria is a
potentially fatal disease, usually curable if diagnosed
quickly [8]. The World Health Organization has recog-
nized the urgent need for simple and cost effective diag-
nostic tests for malaria to overcome the deficiencies of
both light microscopy and clinical diagnosis [9]. The need
for a simple, sensitive diagnostic test has led to the devel-
opment of rapid diagnostic tests (RDTs) among other
alternative techniques. Initially the use of RDTs met stiff
resistance by the malaria community because of its cost.
However, a number of reports from policy makers have
acknowledged that RDTs may have their place because
expert microscopy in malaria-endemic countries is hard
to establish and cost of RDTs has been greatly reduced
[10]. Further, the recently introduced artemisinin based
combination therapy (ACT) is given to patients only
when the diagnosis has been confirmed parasitologically.
However, providing parasitological results at all levels of
health care presents a serious challenge. Expanding the
use of blood slide microscopy is a possible solution but
the cost and logistic challenges in remote area restricts
the use of microscopy to hospitals and well-equipped lab-
oratories. It takes great skill and years of experience to
learn to accurately read a malaria slide. The use of RDTs
for Plasmodium falciparum malaria is being imple-
mented by National Vector Borne Disease Control Pro-
gramme (NVBDCP) to improve diagnostic efficiency in
peripheral health care settings in central India. Further,
although P. falciparum causes the most severe disease,
recent reports of significant morbidity and drug resis-
tance in Plasmodium vivax infections are generating new
interest in P. vivax [11,12]. The first generation RDT tests
were specific for P. falciparum [13-15], but the develop-
ment of new rapid tests by including a Pan-malaria test
line allowed detection of non-falciparum infections also
[16,17]. Subsequently increasing numbers of similar
products have been developed [7,18,19].
Figure 1 (A) Map of India showing Madhya Pradesh, (B) Shivpuri and Dindori district.
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Page 3 of 13We undertook a study on evaluation to assess the per-
formance of commercially available malaria RDTs in
comparison with microscopy and polymerase chain reac-
tion (PCR) in an area where both P. falciparum and P.
vivax are co-endemic. This would allow direct product
comparisons that would assist the policy makers and pro-
gramme managers in taking procurement decisions and
would ultimately encourage improvement in the quality
of manufacturing. Five RDTs evaluated for this purpose
were selected on the basis of two main criteria i.e. tests
detecting both P. falciparum and non-falciparum infec-
tions and commercial availability.
Methods
Study area
The study was conducted in 10 villages of Bajag Primary
Health Centre of district Dindori (22°57' N latitude and
81°41' E longitude) between August to December, 2009.
Figure 2 Total field clinic attendance and patients recruited for malaria screening by Rapid Diagnostic Tests, Microscopy and PCR.
No. Screened (409) 
Recruited (372) 
Microscopy Results 






61 mono P.falciparum 
4 mono P.vivax 
117 non parasitaemic 
Falcivax 
62 mono P.falciparum 
2 mono P.vivax 
118 non parasitaemic 
Malascan 
67 mono P.falciparum 
5 mono P.vivax 
110 non parasitaemic 
First Response 
66 mono P.falciparum 
9 mono P.vivax 
107 non parasitaemic 
ParaHIT Total 
42 mono P.falciparum 
0 mono P.vivax 
140 non parasitaemic 
PCR 
43 mono P.falciparum 
9 mono P.vivax 









114 mono P.falciparum 
2 mono P.vivax 
6 non parasitaemic 
Falcivax 
114 mono P.falciparum 
1 mono P.vivax 
7 non parasitaemic 
Malascan 
114 mono P.falciparum 
2 mono P.vivax 
6 non parasitaemic 
First Response 
115 mono P.falciparum 
2 mono P.vivax 
5 non parasitaemic 
ParaHIT Total 
105 mono P.falciparum 
0 mono P.vivax 
17 non parasitaemic 
PCR 
98 mono P.falciparum 
1 mono P.vivax 
7 Mixed; 8 non para. 
Parascreen 
44 mono P.vivax 
5 mono P.falciparum 
1 Mixed; 7 non para. 
Falcivax 
39 mono P.vivax 
2 mono P.falciparum 
1 Mixed; 15 non para. 
Malascan 
39 mono P.vivax 
5 mono P.falciparum 
1 Mixed; 12 non para. 
First Response 
48 mono P.vivax 
5 mono P.falciparum 
1 Mixed; 3 non para. 
ParaHIT Total 
9 mono P.vivax 
3 mono P.falciparum 
1 Mixed; 44 non para. 
PCR 
49 mono P.vivax 
0 mono P.falciparum 
8 Mixed; 0 non para. 
Parascreen 
5 Mixed (Pf+Pv) 
6 mono P.falciparum 
0 mono Pv; 0 non para. 
Falcivax 
5 Mixed (Pf+Pv) 
6 mono P.falciparum 
0 mono Pv; 0 non para. 
Malascan 
5 Mixed (Pf+Pv) 
6 mono P.falciparum 
0 mono Pv; 0 non para. 
First Response 
5 Mixed (Pf+Pv) 
6 mono P.falciparum 
0 mono Pv; 0 non para. 
ParaHIT Total 
2 Mixed (Pf+Pv) 
5 mono P.falciparum 
0 mono Pv; 4 non para. 
PCR 
10 Mixed (Pf+Pv) 
0 mono P.falciparum 






















































Falcivax (Pv/Pf) Frist Response Malaria 
pLDH/HRP2 combo
Para HIT Total
Plasmodium species targeted 
(F= P.falciparumV = P.vivaxP = PAN)
P,F F,P F,V F,P F,P
Target Antigen HRP2/pLDH HRP2/Aldolase HRP2/Vivax specific pLDH HRP2/pLDH HRP2/Aldolase/pLDH
Format Cassette Cassette Cassette Cassette Dipstick
Sequence and type of bound antibody C √ √ √ √ √
T1 pLDH Aldolase pLDH pLDH Aldolase/pLDH
T2 HRP2 HRP2 HRP2 HRP2 HRP2
Required Volume (μ) of whole blood 5 5 5 5 8
Buffer Volume 4 Drops 4 Drops 4 Drops 2 Drops 4 Drops
Intermediate step - - - - Buffer into tube blood 
on stick, stick on tube
Time to results (mins) 15 15 15 20 15
Maximum Reading time (mins) 30 30 30 - 30
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Page 5 of 13Dindori is a highly malarious district in Madhya Pradesh
(Figure 1) contributing 12% of malaria in the state while
its population is only 1% of state [20]. The villages of
Bajag PHC are very remote, forested and inaccessible for
4-6 months during rainy season. The average annual rain-
fall is 1,400 mm. The inhabitants of these villages are eth-
nic group of Baiga primitive tribe. They are very poorly
clothed and have immense faith in sorcery and witch-
craft. There is no public transport system and health
facilities are non-existent. Plasmodium falciparum is the
predominant infection. The RDT evaluation was also car-
ried out in 10 villages of Satanwada Primary Health Cen-
tre, District Shivpuri (25°4' N latitude and 77°44' E
longitude). The inhabitants of the villages are ethnic
group of Saharia primitive tribe who live in small one
room hutments which are very overcrowded and unhy-
gienic. Plasmodium vivax is the predominant infection in
this area unlike Bajag PHC. The study area is hot, dry and
the average annual rainfall is 875 mm.
Table 2: Comparative performance of Rapid Diagnostic Test kits (Parascreen, Falcivax, Malascan, First Response and 
ParaHIT Total) with traditional light microscopy and Polymerase Chain Reaction (PCR) for diagnosis of Malaria
Parascreen Falcivax Malascan First Response ParaHIT Total
Light Microscopy as Gold Standard (Reference)
Sensitivity 93.2 88.4 90.5 95.8 65.8
(95% CI) (88.6-96.3) (83.0-92.6) (85.4-94.3) (91.9-98.2) (58.6-72.5)
Specificity 64.3 64.8 60.4 58.8 76.9
(95% CI) (56.9-71.2) (57.4-71.8) (52.9-67.6) (51.3-66.0) (70.1-82.8)
Positive Likelihood Ratio 2.6 2.5 2.3 2.3 2.9
(95% CI) (2.1-3.2) (2.1-3.1) (1.9-2.8) (1.9-2.8) (2.2-3.8)
Negative Likelihood Ratio 0.1 0.2 0.2 0.1 0.44
(95% CI) (0.1-0.2) (0.1-0.3) (0.1-0.3) (0.04-0.14) (0.36-0.55)
Positive Predictive Value 73.1 72.4 70.5 70.8 74.9
(95% CI) (67.1-78.6) (67.2-78.1) (64.3-76.1) (64.8-76.3) (67.6-81.2)
Negative Predictive Value 90.0 84.3 85.9 93.0 68.3
(95% CI) (83.5-94.6) (77.2-89.9) (78.7-91.4) (86.8-96.9) (61.4-74.6)
Percentage Agreement (Accuracy) 79.0 76.9 75.8 77.7 71.2
Kappa 0.58 0.53 0.51 0.55 0.43
PCR as Gold Standard (Reference)
Sensitivity 86.6 83.1 85.7 89.2 61.0
(95% CI) (81.5-90.7) (77.7-87.7) (80.5-90.0) (84.4-92.9) (54.4-67.4)
Specificity 73.7 75.2 70.7 67.7 85.0
(95% CI) (65.3-80.9) (67.0-82.3) (62.2-78.2) (59.0-75.5) (77.7-90.6)
Positive Likelihood Ratio 3.3 3.4 2.9 2.8 4.1
(95% CI) (2.5-4.4) (2.5-4.5) (2.2-3.8) (2.2-3.5) (2.7-6.2)
Negative Likelihood Ratio 0.2 0.2 0.2 0.2 0.46
(95% CI) (0.1-0.3) (0.2-0.3) (0.1-0.3) (0.11-0.24) (0.38-0.55)
Positive Predictive Value 85.1 85.3 83.5 82.7 87.6
(95% CI) (79.9-89.4) (80.0-89.7) (78.2-88.0) (77.5-87.2) (81.5-92.2)
Negative Predictive Value 76.0 71.9 74.0 78.3 55.7
(95% CI) (67.7-83.1) (63.7-79.2) (65.5-81.4) (69.6-85.4) (48.5-62.6)
Percentage Agreement (Accuracy) 81.9 80.2 80.2 81.3 69.8
Kappa 0.61 0.58 0.57 0.59 0.41
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All patients irrespective of their age and sex except preg-
nant women presenting at the field clinic with a clinical
suspicion of malaria were included in the study after tak-
ing written informed consent. This study was approved
by the ethics committee of the Regional Medical
Research Centre (ICMR).
Demographic and clinical information was recorded
from each patient and all five RDTs were tested simulta-
neously in field in parallel with peripheral blood smear
for microscopic examination in the laboratory. Before the
initiation of the study, a one-day workshop was organized
to provide training in blood collection from finger prick,
test procedure for each RDT and interpretation of the
test results as per manufacturer's instructions. The
results of each RDT were recorded between 15-30 min-
utes as per the manufacturer's instructions. 2-3 drops of
finger prick blood samples were also collected in hepa-
rinised tube/filter paper for PCR to be conducted in the
laboratory.
Table 3: Comparative performance of Rapid Diagnostic Test kits (Parascreen, Falcivax, Malascan, First Response and 
ParaHIT Total) with traditional light microscopy and Polymerase Chain Reaction (PCR) for diagnosis of P.falciparum
Parascreen Falcivax Malascan First Response ParaHIT Total
Light Microscopy as Gold Standard (Reference)
Sensitivity 94.0 94.0 94.0 94.7 84.2
(95% CI) (88.52-97.4) (88.5-97.4) (88.5-97.4) (89.5-97.7) (76.9-90.0)
Specificity 72.0 72.8 69.5 69.9 80.8
(95% CI) (65.8-77.6) (66.7-78.3) (63.2-75.2) (63.6-75.6) (75.2-85.6)
Positive Likelihood Ratio 3.4 3.46 3.08 3.14 4.38
(95% CI) (2.7-4.1) (2.80-4.27) (2.53-3.74) (2.58-3.83) (3.34-5.73)
Negative Likelihood Ratio 0.08 0.08 0.09 0.08 0.20
(95% CI) (0.04-0.16) (0.04-0.16) (0.04-0.17) (0.04-0.16) (0.13-0.29)
Positive Predictive Value 65.1 65.8 63.1 63.6 70.9
(95% CI) (57.9-71.8) (58.6-72.5) (56.0-69.9) (56.5-70.3) (63.1-77.8)
Negative Predictive Value 95.6 95.6 95.4 96.0 90.2
(95% CI) (91.4-98.1) (91.5-98.1) (91.1-98.0) (91.9-98.4) (85.4-93.8)
Percentage Agreement (Accuracy) 79.8 80.4 78.2 78.8 82.0
Kappa 0.60 0.61 0.57 0.58 0.62
PCR as Gold Standard (Reference)
Sensitivity 83.6 84.8 84.8 83.6 73.7
(95% CI) (77.2-88.8) (78.5-89.8) (78.5-89.8) (77.2-88.8) (66.4-80.1)
Specificity 78.2 80.3 76.2 75.6 86.5
(95% CI) (71.7-83.8) (74.0-85.7) (69.5-82.0) (69.0-81.5) (80.9-91.0)
Positive Likelihood Ratio 3.84 4.31 3.56 3.43 5.47
(95% CI) (2.92-5.06) (3.22-5.77) (2.74-4.61) (2.65-4.44) (3.78-7.91)
Negative Likelihood Ratio 0.21 0.19 0.20 0.22 0.30
(95% CI) (0.15-0.30) (0.13-0.27) (0.14-0.29) (0.15-0.31) (0.24-0.39)
Positive Predictive Value 77.3 79.2 75.9 75.3 82.9
(95% CI) (70.62-83.1) (72.6-84.9) (69.2-89.8) (68.5-81.2) (76.0-88.5)
Negative Predictive Value 84.4 85.6 85.0 83.9 78.8
(95% CI) (78.2-89.3) (79.7-90.4) (78.8-89.9) (77.6-89.0) (72.6-84.1)
Percentage Agreement (Accuracy) 80.8 82.4 80.2 79.4 80.5
Kappa 0.62 0.65 0.61 0.59 0.61
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Page 7 of 13The five RDTs used in this study are - Parascreen
Device (rapid test for malaria Pan/Pf ), Falcivax Device
(rapid test for malaria Pv/Pf), Malascan Device (rapid test
for malaria Pf/Pan) (all from Zephyer Biomedicals Goa),
ParaHIT Total (rapid test for Pf & Pan Malaria species)
(SPAN Diagnostics Ltd, Surat) and First Response
Malaria Antigen Combo Card test (pLDH/HRP2) (Pre-
mier medical corporation Mumbai). These RDTs were
provided by their manufacturers for the evaluation. The
detailed characteristics of each test are shown in Table 1.
All RDTs were tested by two Research Assistants to
minimize variability. The blood films were examined by
an experienced microscopist in the laboratory without
reference to the results of RDTs and clinical history of
patient. The results of both microscopy and RDTs were
matched by an independent expert. A slide was consid-
ered positive if atleast one asexual form of parasite was
detected in 100 microscopic fields in thick blood film.
Blood parasite density was determined from the thick
films by counting the number of parasites against 200
Table 4: Comparative performance of Rapid Diagnostic Test kits (Parascreen, Falcivax, Malascan, First Response and 
ParaHIT Total) with traditional light microscopy and Polymerase Chain Reaction (PCR) for diagnosis of P.vivax
Parascreen Falcivax Malascan First Response ParaHIT Total
Light Microscopy as Gold Standard (Reference)
Sensitivity 77.2 68.4 68.4 84.2 15.8
(95% CI) (64.2-87.3) (54.8-80.1) (54.8-80.1) (72.1-92.5) (7.5-27.9)
Specificity 98.1 99.0 97.8 96.5 100.0
(95% CI) (95.9-99.3) (97.2-99.8) (95.5-99.1) (93.8-98.2) (98.8-100.0)
Positive Likelihood Ratio 40.5 71.8 30.8 24.1
(95% CI) (18.1-90.6) (23.0-224.6) (14.5-65.4) (13.4-43.6)
Negative Likelihood Ratio 0.23 0.32 0.32 0.16 0.84
(95% CI) (0.14-0.37) (0.22-0.47) (0.22-0.47) (0.09-0.30) (0.75-0.94)
Positive Predictive Value 88.0 92.9 84.8 81.4 100.0
(95% CI) (75.7-95.5) (80.5-98.5) (71.1-93.7) (69.1-90.3) (66.4-100.0)
Negative Predictive Value 96.0 94.5 94.5 97.1 86.8
(95% CI) (93.2-97.8) (91.5-96.7) (91.4-96.7) (94.6-98.7) (82.9-90.1)
Percentage Agreement (Accuracy) 94.9 94.4 93.3 94.6 87.1
Kappa 0.80 0.76 0.72 0.80 0.24
PCR as Gold Standard (Reference)
Sensitivity 68.3 61.7 63.3 76.7 13.3
(95% CI) (55.0-79.7) (48.2-73.9) (49.9-75.4) (64.0-86.6) (5.9-24.6)
Specificity 97.0 98.4 97.4 95.7 99.7
(95% CI) (94.5-98.6) (96.2-99.5) (94.9-98.9) (92.8-97.7) (98.2-100.0)
Positive Likelihood Ratio 23.1 37.5 24.1 17.9 40.5
(95% CI) (11.9-44.9) (15.4-91.5) (11.8-49.0) (10.4-31.1) (5.2-318.1)
Negative Likelihood Ratio 0.33 0.39 0.38 0.24 0.87
(95% CI) (0.22-0.47) (0.28-0.54) (0.27-0.53) (0.15-0.39) (0.79-0.96)
Positive Predictive Value 82.0 88.1 82.6 78.0 88.9
(95% CI) (68.6-91.4) (74.4-96.0) (68.6.-92.2) (65.3-87.7) (51.8-99.7)
Negative Predictive Value 93.9 92.9 93.1 95.4 85.4
(95% CI) (90.7-96.3) (89.5-95.4) (89.7-95.6) (92.4-97.5) (81.2-88.9)
Percentage Agreement (Accuracy) 92.3 92.3 91.8 92.6 85.4
Kappa 0.70 0.68 0.67 0.73 0.20
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Page 8 of 13white blood cells (WBC) and assuming that each subject
had 8000 white blood cells/μl of blood. All negative slides
that test positive on the RDT/PCR or all positive slides
that test negative on the RDT/PCR were re-examined by
another expert technician blinded to the results of
microscopy, RDT/PCR and clinical status of the patients.
The PCR was performed blind on coded samples by an
independent Research Assistant unaware of clinical sta-
tus of patients, result of RDTs and microscopic examina-
tion. Every person positive for falciparum malaria by
RDT or by microscopy was treated with a combination of
artesunate and sulphadoxine-pyremethamine (ACT) or
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Page 9 of 13with chloroquine (CQ) if RDT/microscopy showed non-
falciparum infection.
For testing temperature stability of the tests, RDTs were
stored at 25°C on receipt in the study sites, then allocated
to separate groups for storage at 35°C & 45°C for 90 days,
at 60°C for 48 hours, and at -10°C for 60 minutes before
testing [21]. At the start of the study, the incubators were
stabilized at the required temperature for three days
before the RDTs to be tested were placed inside. RDTs
were removed from storage to reach room temperature
for 2 hours before testing and comparisons were made
with control RDTs kept at 25°C until use and with
microscopy. The malaria RDTs used in this study were
from single lots of commercially available products.
Polymerase chain reaction
The DNA was isolated from the blood by using the com-
mercially available DNA extraction kit (Bio Basic Inc) as
per manufacturer protocol and also from archive blood
spots by Tris-EDTA (TE) buffer method. PCR for the
identification of malaria parasite was performed follow-
ing the standard methods [22].
Data analysis
Results of the RDT and microscopy examination were
recorded on separate forms. After double key data entry,
the database was rechecked for all inconsistent entries
and errors were corrected. Data were then analysed using
STATA 8.2 (StataCorp, College Station Texas, USA). The
figures for sensitivity, specificity, predictive values, accu-
racy, the area under the receiver operator characteristic
curve (AUC) and the likelihood ratios were calculated
using the 'diagt' command in Stata [23]. All estimated
parameters are detailed with a 95% Confidence Interval
(CI) unless stated otherwise.
Results
During the study period, 409 patients (age 1 to 69 years)
attended the two sites 236 patients (57.7%) were screened
at Dindori and 173 (42.2%) were screened at Shivpuri
(mean age 15.45 ± 14.15). 37 patients (9%) were excluded
as not fulfilling the study enrolment criteria due to recent
anti-malarial intake. 372 patients were eligible and all
these patients were recruited (mean age 15.03 ± 14.07).
All recruited patients were tested by microscopy, RDT
and PCR (Figure 2).
A total of 190 (51.1%) were found infected by micros-
copy, 57 (15.3%) with P. vivax, 122 with P. falciparum
(32.8%) and 11 (3%) with both P. vivax and P. falciparum.
The overall sensitivity and specificity of First Response
for malaria was 95.8 and 58.8%, Parascreen 93.2 and
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Page 10 of 1364.3%, Malascan 90.5 and 60.4%, Falcivax 88.4 and 64.8%
and by ParaHIT Total 65.8 and 76.9% respectively (Table
2). The highest sensitivity was recorded by First Response
and was considered here as reference test for comparing
the sensitivity and specificity of other RDTs. Parascreen
was found to be 41% less sensitive than First Response
(OR 0.59, 95%CI 0.24 - 1.48), though, this difference was
not significant statistically (P > 0.05). Falcivax was 67%
less sensitive (OR 0.33, 95%CI 0.14 - 0.78) and Malascan
was 58% less sensitive (OR 0.42, 95%CI 0.18 - 1.00) than
First Response and these differences were significant sta-
tistically (P < 0.05). ParaHIT Total showed lowest sensi-
tivity (OR 0.08, 95% CI 0.04 - 0.19) and highly significant
statistically (P < 0.0001). Thus, Parascreen was the first
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Page 11 of 13alternative to First Response. Similarly, further analysis
showed that the specificity of Parascreen, Falcivax and
Malascan were 1.07 to 1.26 times more when compared
to First Response which is not significant (P > 0.05). How-
ever, specificity of ParaHIT Total was more than 2 times
when compared to the First Response (OR 2.34, 95% CI
1.47 - 3.71), which was highly significant statistically.
The species wise analysis revealed that the sensitivity
for P. falciparum was highest (94.7%) by First Response
(Table 3), while lowest for ParaHIT Total, (84.2%). The
specificity for P. falciparum was highest (80.8%) by Para-
HIT Total while lowest 69.5% by Malascan. The positive
predictive value (PPV) for P. falciparum was highest by
ParaHIT Total (70.9%) while lowest by Malascan (63.1%).
The negative predictive value (NPV) was highest (96.0%)
by First Response while lowest (90.2%) by ParaHIT Total.
The false positive rate for P. falciparum was highest
(30.5%) by Malascan (73/239) while lowest (19.2%) by
ParaHIT Total (46/239). Like wise the false negative rate
for P. falciparum was highest (15.8%) by ParaHIT Total
(21/133) and lowest (5.3%) by First Response (7/133).
When PCR was used as a reference standard the corre-
sponding values for sensitivity, specificity, PPV, NPV and
accuracy for each RDT are shown in Table 3.
For non-falciparum infections i.e. P. vivax the sensitiv-
ity of the test when compared with microscopy was 84.2%
by First Response, while only 15.8% by ParaHIT Total
(Table 4). Specificity of the test was 100% by ParaHIT
Total and 96.5% by First Response. Similarly, PPV was
highest (100%) for ParaHIT Total while lowest (81.4%) for
First Response. On the contrary, NPV was highest for
First Response (97.1%) while lowest (86.8%) by ParaHIT
Total. False positive rate for P. vivax was highest (3.5%) by
First Response (11/315) and none by ParaHIT Total (0/
315). On the contrary, false negative rate for P. vivax was
lowest (15.8%) by First Response (9/57) and highest
(84.2%) by ParaHIT Total (48/57). The values of sensitiv-
ity, specificity, PPV, NPV and accuracy using PCR as ref-
erence standard are shown in Table 4. Area under
Receiver Operating Characteristic (ROC) curve (AUC) of
five RDTs vs microscopy was computed for diagnosing
malaria, P. falciparum and P. vivax (Figure 3) The AUC of
different RDTs were significantly different for malaria (χ2
= 18.21, P < 0.001), and for P. vivax (χ2 = 108.29, P <
0.0001) but not significant for P. falciparum (χ2 = 8.47, P >
0.05).
The analysis of RDTs sensitivity according to parasitae-
mia revealed that the First Response was most sensitive
for diagnosis of P. falciparum (95.0%) and P. vivax (88.0%)
malaria as compared to other 4 RDTs especially for levels
of parasitaemia above 200 parasite/μl (Figure 4). It should
be noted that in this study because of the requirement for
fever in patients from a high transmission area, there
were no cases in which the parasite density was ≤ 40 par-
asites/μl.
Analysis of intensity of band and parasite density
revealed that there was a weaker correlation in band
intensity and parasite density for ParaHIT Total r = 0.13
(P > 0.05). Although all other four RDTs was also showing
a weak positive correlation in band intensity and parasite
density but it was statistically significant r = 0.17 (P <
0.025). Species wise further analysis revealed that in P.
vivax all four RDTs i.e. Parascreen, Falcivax, Malascan
and First Response showed very strong positive correla-
tion in band intensity and parasite density (r = 0.50, P <
0.0001) while no statistically significant correlation was
seen in P. falciparum (Figure 5).
Further, exposure of all RDTs to high temperature i.e.
35°C, 45° & 60°C and low temperature (-10°C) did not
cause any loss of sensitivity for both P. falciparum and P.
vivax except ParaHIT Total when compared with micros-
copy and PCR. However, there was some reduction in test
line-intensity at high temperature.
Discussion
This comparative evaluation was carried out in outbreak-
affected areas. From a malaria transmission perspective
in both the areas, the RDTs can play a key role in rapid
diagnosis and prompt treatment of malaria where resis-
tance to CQ also necessitates the use of more expensive
ACT. As RDT can be conducted immediately in the field
clinic while the patient is present, the most important
point for the villagers is the knowledge that they are
infected with malaria parasite. On the contrary, the delay
in the results of microscopic diagnosis is a serious obsta-
cle for the operation of a malaria control programme in
remote areas. Despite some inherent limitations, out of
five tests evaluated, the First response was highly sensi-
tive for the diagnosis of P. falciparum and non-falciparum
especially for levels of parasitaemia above 200 parasite/μl.
On the other hand its specificity was much lower than its
sensitivity. Having a relatively low specificity which leads
to an over-diagnosis and to an over treatment of non-
malaria cases was, however, considered as less serious in
such outbreak affected areas than having a low sensitivity
which may lead to a potentially fatal condition being
missed [24]. However, in a field setting such as ours, a
negative RDT corresponds in the vast majority of cases to
a non-infected individual. The high NPV allow us to con-
fidently diagnose negative test patients as non-malaria
patients [25]. Thus the risk of missing an infected individ-
ual is very small by most RDTs used in this evaluation. In
Ethiopia high NPV was also recorded using Parascreen
RDT in a population-based study [26] and in a health
facility based study [27]. However, the sensitivity of all
RDTs except First Response for non-P. falciparum infec-
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Page 12 of 13tions is low (16-77%) as reported earlier from India using
First Response and Falcivax RDTs [19,28].
The performance of RDTs can be adversely affected at
the temperature to which they are exposed when trans-
ported [21]. Temperatures of 35°C to 45°C are common in
malaria-endemic regions and higher temperatures may
be encountered during transportation. Further inadver-
tent freezing has also been recorded during routine ship-
ment [29]. All types of RDTs (except ParaHIT Total)
perform satisfactorily at all temperatures although we do
not know whether the performance of RDTs will be
equally good at low parasitaemia as recorded by some
investigators [21].
A diagnostic test which is to be used in a peripheral
health facility, particularly in resource poor areas, has to
be simple and fast to perform by less qualified staff.
Among the five RDTs tested, First Response require 20
minutes while all other RDTs require 30 minutes before
classifying the RDT as negative test. Further, the First
Response need only 2 drop of buffer while all other RDTs
need 4 drops. Thus the First Response clearly has an
advantage over other RDTs.
Conclusions
The two potential alternatives to microscopy are, PCR
and RDTs. Primers exist for the reliable identification of
the human malarias by PCR assays [22,30]. However, this
is largely a research tool unsuited for routine use in the
field or clinical laboratory. Given the logistic and financial
difficulties of the PCR in field settings, only microscopy
and RDTs are viable options at present and PCR remain a
future alternative to these tests when inexpensive hand
held diagnostic point of care (POC) instrumentation to
detect malaria is available [31]. The practical and fast
nature of RDTs make them the only currently viable sup-
plement to or replacement of microscopy based diagno-
sis. Thus, RDTs could play and will play an important role
in malaria diagnosis in the future. However, there are res-
ervations about how well these RDTs perform as many
commercially available RDTs lack the consistency, quality
control and performance capabilities as claimed by the
manufacturers making their use ineffective or potentially
dangerous [32]. Further, can RDTs be operated by villag-
ers, school-teachers or forest workers, in forested inac-
cessible areas so that they can penetrate into areas where
microscope and health facilities are non existent? This is
an important question which can only be answered when
more experimental next generation RDTs are available.
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